Frans K. Gorus
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Non-HLA Risk Loci ERBB3/IKZF4 and ERBB2/IKZF3/GSDMB/ORMDL3 Interact to Influence Progression of Autoimmunity in Relatives of T1D Patients.
Journal: Diabetes/metabolism research and reviews
Published: December 17, 2025
Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis.
Journal: Diabetes care
Published: October 30, 2024
Baseline plasma proinsulin response to glucose for predicting therapeutic response to otelixizumab in recent-onset type 1 diabetes.
Journal: Diabetes research and clinical practice
Published: May 10, 2023
CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients.
Journal: Clinical and experimental immunology
Published: October 06, 2022
Age-period-cohort modelling of type 1 diabetes incidence rates among children included in the EURODIAB 25-year follow-up study.
Journal: Acta diabetologica
Published: July 26, 2022
Insulitis in the pancreas of non-diabetic organ donors under age 25 years with multiple circulating autoantibodies against islet cell antigens.
Journal: Virchows Archiv : an international journal of pathology
Published: November 19, 2020
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes.
Journal: Diabetologia
Published: May 14, 2020
Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review.
Journal: European journal of endocrinology
Published: April 17, 2019
Last Updated: 09/26/2026